Mushrooms – read carefully and watch the film – you’ll drop out.

Reishi has been shown in clinical studies to support immune function and promote immune cell proliferation both in animal and in vitro clinical studies. An unpublished, comparative study conducted by the Medical Institute at National Taiwan University found that ReishiMax GLp supported immune function when compared to a placebo. A study comparing reishi products from China, Taiwan, and the U.S. found ReishiMax GLp to be the most potent and effective Reishi product available.**
**Daniel Sliva, Ph.D., Miroslav Sedlak, Ph.D. et al. Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. The Journal of Alternative and Complementary Medicine, 2003; 9(4): 491–497.

Free Register Wholesale price. Sponzor ID Alexander Vasko SK5500064.


Video, resource sharing Netflix document.


ReishiMax GLp is a standardized Reishi mushroom extract that incorporates cracked spores, a proprietary technology that releases Reishi’s active ingredients, providing unique immune system activity not found in other Reishi products. *

Yang J, Wu Z, Yao Y, Zhang Y, Zhao C, Dong Y, Tan NZ, Zhu JS. ReishiMax improves antioxidant capacity in an oxidative stress model and extends lifespan in a natural aging model. FASEB J. April 2012 (26): 373.2.

Wu Z, Zhang Y, Tan NZ, Zhao C, Zhu JS. ReishiMax extends the lifespan of mice: A preliminary report  FASEB J, 2011 25:Abstract #601.2.

Tan NZ1, Zhang Y1, Yang J1, Zhao C1, Zhu JS2,3. ReishiMax extends the lifespan in an aging model: A preliminary report. FASEB J. April 2010 (24): Abstract #738.5.

Thyagarajan-Sahu A, Lane B, Sliva D. ReishiMax, mushroom based dietary supplement, inhibits adipocyte differentiation, stimulates glucose uptake and activates AMPK. BMC Complement Altern Med. 2011 Sep 19;11:74.

Thyagarajan A, Jedinak A, Nguyen H, Terry C, Baldridge LA, Jiang J, Sliva D. Nutr Cancer. 2010;62(5):630-40.

Adamec J, Jannasch A, Dudhgaonkar S, Jedinak A, Sedlak M, Sliva D. Development of a new method for improved identification and relative quantification of unknown metabolites in complex samples: determination of a triterpenoid metabolic fingerprint for the in situ characterization of Ganoderma bioactive compounds. J Sep Sci. 2009 Dec;32(23-24):4052-8.

Dudhgaonkar S, Thyagarajan A, Sliva D. Int Immunopharmacol. 2009 Oct;9(11):1272-80.

Zhang Y, Zhang L, Tan NZ, Qi Y, Gao L, Zhu JS FASEB J. March 2008 22 (Meeting Abstract Supplement) 1136.2.

Thyagarajan A, Zhu J, Sliva D. International Journal of Oncology. 2007 Apr;30(4):963-9.

Chen W, Zhang Y, Tan NZ, Qi Y, Zhu JS. FASEB J. Meeting Abstracts, 2007, 21(6): Abstract# 852.3.

Sliva, D, and Thyagararjan, A., Acta Pharmacologica Sinica [Abstracts of the 15th World Congress of Pharmacology, July 2-7, 2006, Beijing, China] 2006 July; Supplement 1:1-489. (pg. 338).

Thyagarajan A, Jiang J, Hopf A, Adamec J, Sliva D. International Journal of Molecular Medicine. 2006 Oct;18(4):657-64.

Thyagarajan A, Jiang J, Stanley G, Sliva D.  FASEB J., 2006; 20(5):A1012, Abstract# 652.6.

Jiang J, Slivova V, Sliva D. International Journal of Oncology, 2006, 29(3), 695–703.

Stanley G, Harvey K, Slivova V, Jiang J, Sliva D. Biochem Biophys Res Commun. 2005 Apr 29;330(1):46-52.

Jiang J, Slivova V, Harvey V, Valachovicova T, and Sliva D. Nutrition and Cancer, 2004, 49(2), 209–216.

Slivovas, V., Valachoviciva, T., Jiang, J., Sliva, D. Journal of Cancer Integrative Medicine, 2004; 2:1, pp. 25-30.

Sliva, D., Sedlak, M., Slivova, V., Valachovicova, T., Lloyd, F., HO, NW. Journal of Alternative and Complementary Medicine, 2003; 9:4, pp. 491-497.

Lu QYa, Jin YSb, Zhang Qa, Zhang Zc, Heber Da, Go VLa, Li FPd, Rao JYb. Cancer Letters. 2004;216 (1):9-20.

Lin, W.C., Wu, Y.W., Xie, M.C., Zhu, J.S., FASEB J. 2004; 18(4): A999 (Abstract #650.7).

Jiang, J., Slivova, V., Valachovicova, T., Harvey, K., Sliva, D. International Journal of Oncology, 2004, 24: 1093-1099.

Zhao, C., Zhang, Y., Yin, W., Zhang, D., Guo, F., Zhu, JS. FASEB J., 17: A1099, 2003, Abstract# 689.4.

Wang YY, Wong CH, et al. Bioorganic & Medicinal Chemistry 2002;10:1057-1062.

Ma J, Ye Q, Hua Y, Zhang D, Cooper R, Chang MN, Chang JY, Sun HH. New lanostanoids from the mushroom Ganoderma lucidum. Journal of Natural Product, 2002 Jan;65(1):72-5.

Li C, Li Y, Sun HH. New ganoderic acids, bioactive triterpenoid metabolites from the mushroom Ganoderma lucidum. Nat Prod Res. 2006 Sep;20(11):985-91.

Li C, Yin J, Guo F, Zhang D, Sun HH: Ganoderic acid Sz, a new lanostanoid from the mushroom Ganoderma lucidum. Nat Prod Res. 2005 July; 19(5), 461–465.

Tan N-Z, Chiang B-L, Thyagarajan A, Sliva D, Zhao C-S, Zhang Y, Zhu J-S. Proceedings of The 2011 International Meeting on Ganoderma Research. Aug. 17, 2011 Beijing. pp 44-46. Link

Yang JY, Zhang Y, Zhao C-S, Tan N-Z, Zhu J-S. Anti-oxidation and lifespan-extension activities of ReishiMax in oxidative stress and aging models. Proceedings of The 2011 International Meeting on Ganoderma Research. Aug. 17, 2011 Beijing. pp 47-49.

Tan NZ, Li CL, Thyagarajan A, Sliva D, Zhang Y, Gao L, Zhu J-S. Proceedings of 2008 Symposium of Chin Asso Med Mycol. Oct 7-9, 2008 Nanchang, Jiangxi. Chinese Association of Medicinal Mycology Publishing, pp 165-171. Link

#vitality #health #wellness #energy #healthylifestyle #nutrition #fitness #ps #healthy #love #fr #healthyfood #solary #balance #healing #vegan #lifestyle #wellbeing #fortnite #gotaga #honey #selfcare #vitamins #youtube #healthyliving #wellnessjourney #nature #meditation #lebouseuh #immunesystem

Categories Uncategorized

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close